Potential spin-off of CVS Health's drugstore business comes amid mounting political pressure on pharmacy benefit managers and health insurers. The company is exploring ways to divest a $117bn healthcare empire, a move that could reshape the U.S. pharmaceutical and retail healthcare landscape.
Source: Financial Times Companies · Summarized by HeadlinesBriefing